
Brian Abrahams
Stock Analyst at RBC Capital
(4.46)
# 1,179
Out of 5,144 analysts
1863
Total ratings
48.3%
Success rate
7.7%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $600 | $550.87 | +8.92% | 155 | Nov 18, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $66 → $70 | $35.39 | +97.80% | 25 | Nov 17, 2026 | |
| AARD Aardvark Therapeutics | Maintained: Hold | $2.5 | $1.35 | +85.19% | 13 | Nov 17, 2026 | |
| GHRS GH Research | Maintained: Buy | $42 | $19.26 | +118.07% | 11 | Nov 16, 2026 | |
| PLRX Pliant Therapeutics | Maintained: Hold | $2 | $0.7996 | +150.13% | 32 | Nov 13, 2026 | |
| EVMN Evommune | Maintained: Buy | $21 | $7.65 | +174.51% | 8 | Nov 13, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Maintained: Buy | $45 | $33.52 | +34.25% | 61 | Nov 12, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $36 → $33 | $3.52 | +837.50% | 34 | Nov 11, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $70 | $40.45 | +73.05% | 37 | Nov 10, 2026 | |
| ATTO Attovia Therapeutics | Maintained: Buy | $45 | $15.96 | +181.95% | 3 | Nov 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $38 | $16.50 | +130.30% | 18 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $6 | $7.58 | -20.84% | 8 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $18 | $17.24 | +4.41% | 139 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $7.63 | +44.17% | 103 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $24.07 | +66.18% | 5 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $10.30 | +103.88% | 17 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $190 | $168.86 | +12.52% | 99 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $810 → $913 | $919.96 | -0.76% | 88 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $131 | $169.32 | -22.63% | 217 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $114 → $117 | $121.89 | -4.01% | 142 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $112 → $116 | $138.86 | -16.46% | 10 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 → $77 | $65.03 | +18.41% | 104 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $256 → $272 | $254.87 | +6.72% | 203 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.04 | +19,900.00% | 110 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $12.62 | +34.71% | 13 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $35 | $16.14 | +116.85% | 12 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.4859 | +929.02% | 22 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $23 → $5 | $3.57 | +40.06% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $8.78 | +48.15% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 | $93.18 | +37.37% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 | $45.54 | n/a | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $15 | $11.47 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $288 | $17.30 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.85 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $465.23 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $2.54 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $210.78 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $16.41 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $139.85 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $9.49 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $46.62 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $75.03 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $22.79 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $11.05 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $118.21 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $31.24 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $24.51 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $48.85 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $85.25 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $57.18 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $293.30 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $62.14 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.15 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,411.95 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $282.11 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.12 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $148.76 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $29.23 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $163.69 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $42.05 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.57 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.89 | n/a | 1 | Sep 2, 2009 |
Vertex Pharmaceuticals
Nov 18, 2026
Maintained: Buy
Price Target: $600
Current: $550.87
Upside: +8.92%
Definium Therapeutics
Nov 17, 2026
Maintained: Buy
Price Target: $66 → $70
Current: $35.39
Upside: +97.80%
Aardvark Therapeutics
Nov 17, 2026
Maintained: Hold
Price Target: $2.5
Current: $1.35
Upside: +85.19%
GH Research
Nov 16, 2026
Maintained: Buy
Price Target: $42
Current: $19.26
Upside: +118.07%
Pliant Therapeutics
Nov 13, 2026
Maintained: Hold
Price Target: $2
Current: $0.7996
Upside: +150.13%
Evommune
Nov 13, 2026
Maintained: Buy
Price Target: $21
Current: $7.65
Upside: +174.51%
Lakefront Biotherapeutics NV
Nov 12, 2026
Maintained: Buy
Price Target: $45
Current: $33.52
Upside: +34.25%
Corbus Pharmaceuticals Holdings
Nov 11, 2026
Maintained: Buy
Price Target: $36 → $33
Current: $3.52
Upside: +837.50%
Xenon Pharmaceuticals
Nov 10, 2026
Maintained: Buy
Price Target: $70
Current: $40.45
Upside: +73.05%
Attovia Therapeutics
Nov 10, 2026
Maintained: Buy
Price Target: $45
Current: $15.96
Upside: +181.95%
Nov 5, 2026
Rated: Buy
Price Target: $36 → $38
Current: $16.50
Upside: +130.30%
Nov 5, 2026
Reiterated: Hold
Price Target: $40 → $6
Current: $7.58
Upside: -20.84%
Nov 5, 2026
Reiterated: Hold
Price Target: $17 → $18
Current: $17.24
Upside: +4.41%
Nov 4, 2026
Reiterated: Hold
Price Target: $11
Current: $7.63
Upside: +44.17%
Nov 4, 2026
Reiterated: Buy
Price Target: $40
Current: $24.07
Upside: +66.18%
Nov 3, 2026
Reiterated: Buy
Price Target: $21
Current: $10.30
Upside: +103.88%
Nov 2, 2026
Reiterated: Buy
Price Target: $187 → $190
Current: $168.86
Upside: +12.52%
Oct 30, 2026
Rated: Hold
Price Target: $810 → $913
Current: $919.96
Upside: -0.76%
Oct 29, 2026
Reiterated: Hold
Price Target: $126 → $131
Current: $169.32
Upside: -22.63%
Oct 29, 2026
Reiterated: Hold
Price Target: $114 → $117
Current: $121.89
Upside: -4.01%
Oct 29, 2026
Rated: Hold
Price Target: $112 → $116
Current: $138.86
Upside: -16.46%
Oct 29, 2026
Reiterated: Hold
Price Target: $75 → $77
Current: $65.03
Upside: +18.41%
Oct 28, 2026
Rated: Buy
Price Target: $256 → $272
Current: $254.87
Upside: +6.72%
Oct 27, 2026
Reiterated: Buy
Price Target: $8
Current: $0.04
Upside: +19,900.00%
Oct 27, 2026
Reiterated: Hold
Price Target: $17
Current: $12.62
Upside: +34.71%
Oct 12, 2026
Rated: Buy
Price Target: $36 → $35
Current: $16.14
Upside: +116.85%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.4859
Upside: +929.02%
Aug 10, 2026
Upgraded: Hold
Price Target: $23 → $5
Current: $3.57
Upside: +40.06%
Aug 6, 2026
Reiterated: Hold
Price Target: $13
Current: $8.78
Upside: +48.15%
Apr 7, 2026
Reiterated: Buy
Price Target: $128
Current: $93.18
Upside: +37.37%
Oct 26, 2025
Reiterated: Buy
Price Target: $39.00
Current: $45.54
Upside: n/a
Oct 2, 2023
Reiterated: Hold
Price Target: $25 → $15
Current: $11.47
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: $288
Current: $17.30
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: $4
Current: $2.85
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $465.23
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $2.54
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $210.78
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $16.41
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $139.85
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $9.49
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $46.62
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $75.03
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $22.79
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $11.05
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $118.21
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $31.24
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $24.51
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $48.85
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $85.25
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $57.18
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $293.30
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $62.14
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $7.15
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,411.95
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $282.11
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $1.12
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $148.76
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $29.23
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $163.69
Upside: n/a
Feb 23, 2015
Reiterated: Hold
Price Target: n/a
Current: $42.05
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.57
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $10.89
Upside: n/a